Proceedings of the University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands,missing data and sensitivity analysis
Restricted accessOtherFirst published online August, 2019
Proceedings of the University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands,missing data and sensitivity analysis
Guidance for Industry E9 Statistical Principles for Clinical Trials. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Geneva: ICH, 1998.
2.
National Research Council. The prevention and treatment of missing data in clinical trials (Panel on handling missing data in clinical trials. Committee on national statistics, Division of behavioral and social sciences and education). Washington, DC: The National Academies Press, 2010.
3.
EllenbergJHMickREllenbergSS (eds). Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: early, translational and proof of concept studies: the “go/no go” decisions. Stat Med2010; 29(10): 1059–1060.
4.
EllenbergJHEllenbergSS (eds). Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: statistical issues in developing targeted therapies. Clin Trials2010; 7(5): 513–515.
5.
EllenbergJHEllenbergSS (eds). Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: statistical issues in comparative effectiveness research. Clin Trials2012; 9(1): 5.
6.
EllenbergJHEllenbergSS (eds). Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: emerging statistical issues in the conduct and monitoring of clinical trials. Clin Trials2012; 9(6): 669–670.
7.
EllenbergJHEllenbergSS (eds). Proceedings of the University of Pennsylvania 5th annual conference on statistical issues in clinical trials: emerging statistical issues in biomarker validation for clinical trials. Clin Trials2013; 10(5): 645–646.
8.
EllenbergJHEllenbergSS (eds). Proceedings of the University of Pennsylvania 6th annual conference on statistical issues in clinical trials: dynamic treatment regimes. Clin Trials2014; 11(4): 391–392.
9.
EllenbergSSEllenbergJH (eds). Proceedings of the University of Pennsylvania 7th annual conference on statistical issues in clinical trials: the use of biomarkers and surrogate endpoints in clinical trials. Clin Trials2015; 12(4): 297–298.
10.
EllenbergSSEllenbergJH (eds). Proceedings of the University of Pennsylvania eighth annual conference on statistical issues in clinical trials: statistical issues in pragmatic clinical trials. Clin Trials2016; 13(5): 469–470.
11.
EllenbergSSEllenbergJH (eds). Proceedings of the University of Pennsylvania ninth annual conference on statistical issues in clinical trials: where are we with adaptive clinical trial designs. Clin Trials2017; 14(5): 415–416.
12.
EllenbergSSEllenbergJH (eds). Proceedings of the University of Pennsylvania 10th annual conference on statistical issues in clinical trials: current issues regarding data and safety monitoring committees in clinical trials. Clin Trials2018; 15(4): 319–320.
